Thursday, October 22, 2020
1:00pm – 2:00pm EDT
Register here.
Many companies are seeking alternatives to the traditional IPO, and considering merging into a SPAC, or a reverse merger. For life sciences companies, reverse merger transactions have become a popular alternative approach to going public. Merging into a public life sciences company that has…
The National Center of the Middle Market (NCMM) conducted a survey from March 12-23, 2020 of 400 strategic decision makers from life sciences companies in the United States and Canada. The report noted middle market life sciences companies, which include companies with annual revenues between $10 million and $1 billion, have experienced robust growth. Between…
CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies in the global healthcare sector yielded a historic high of $18.1 billion in the second quarter of 2020, and deal volume rose 6% quarter-over-quarter. Total funding was boosted by six mega-rounds, or capital raises over $100 million, in the regenerative…
Sunday, July 19, 2020
9:00 a.m. – 10:00 a.m. EDT
4:00 p.m. – 5:00 p.m. Israel Time
Register here
Join Mayer Brown and PwC for a webinar on Life Sciences IPOs. Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our…
On June 10, 2020, the US Court of Appeals for the Ninth Circuit affirmed the dismissal of a putative securities fraud class action against Endologix, Inc., a medical device company, on the grounds that the shareholder’s core theory of liability had “no basis in logic or common experience.” In that case, Nguyen v. Endologix, Inc.,…
June 17, 2020
9:00 AM – 10:00 AM EDT
Register here.
The US capital markets remain an attractive source of capital for emerging companies in the life sciences sector. A significant percentage of the 2019 U.S. initial public offerings were undertaken by life sciences companies. Despite the market uncertainty and volatility brought about by…
During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a recent CB Insights report, healthcare companies raised $14.6 billion this past quarter in 1,156 deals. Deal volume decreased 6% quarter-over-quarter. The inverse…
March 25, 2020
1:00 – 2:00 PM ET
Register here.
The last few years have seen a dramatic rise in the number of securities class-action cases involving initial public offerings, and this has affected D&O coverage and the costs associated with D&O insurance.
During this webcast, Mike Ferraro and Yelena Dunaevsky from Woodruff Sawyer…
February 21, 2020
1:00 – 2:00 PM ET
Click here to register
The U.S. capital markets remain an attractive source of capital for emerging companies in the life sciences sector. Life sciences continued to represent the most significant percentage by deal volume of IPO activity in 2019. Many of these IPOs were preceded by late…
Thursday, February 27, 2020
Seton Hall University School of Law
8:30 a.m. – 9:00 a.m. Registration
9:00 a.m. – 3:30 p.m. Program
Please visit the event website to register.
We invite you to attend the Hot Topics in Life Sciences Law symposium, presented by Mayer Brown and the Center for Health & Pharmaceutical Law &…
